HEADER LIPID TRANSPORT 29-NOV-02 1O8T TITLE GLOBAL STRUCTURE AND DYNAMICS OF HUMAN APOLIPOPROTEIN CII IN COMPLEX TITLE 2 WITH MICELLES: EVIDENCE FOR INCREASED MOBILITY OF THE HELIX INVOLVED TITLE 3 IN THE ACTIVATION OF LIPOPROTEIN LIPASE COMPND MOL_ID: 1; COMPND 2 MOLECULE: APOLIPOPROTEIN C-II; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: APO-CII; COMPND 5 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 ORGAN: LIVER; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: BL21(DE3); SOURCE 9 EXPRESSION_SYSTEM_VECTOR: PET29A(+); SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PET29A-HAPOCII KEYWDS APOCII, LPL, ACTIVATION MECHANISM, DOMAIN MOTION, SDS, MICELLE, KEYWDS 2 GLOBAL STRUCTURE, LOCAL STRUCTURE, DYNAMICS, HELIX, LIPID TRANSPORT, KEYWDS 3 LIPID DEGRADATION, CHYLOMICRON EXPDTA SOLUTION NMR NUMMDL 68 AUTHOR J.ZDUNEK,G.V.MARTINEZ,J.SCHLEUCHER,P.O.LYCKSELL,Y.YIN,S.NILSSON, AUTHOR 2 Y.SHEN,G.OLIVECRONA,S.WIJMENGA REVDAT 4 15-MAY-24 1O8T 1 REMARK REVDAT 3 24-FEB-09 1O8T 1 VERSN REVDAT 2 07-MAR-03 1O8T 1 REMARK ENDMDL REVDAT 1 27-FEB-03 1O8T 0 JRNL AUTH J.ZDUNEK,G.V.MARTINEZ,J.SCHLEUCHER,P.O.LYCKSELL,Y.YIN, JRNL AUTH 2 S.NILSSON,Y.SHEN,G.OLIVECRONA,S.WIJMENGA JRNL TITL GLOBAL STRUCTURE AND DYNAMICS OF HUMAN APOLIPOPROTEIN CII IN JRNL TITL 2 COMPLEX WITH MICELLES: EVIDENCE FOR INCREASED MOBILITY OF JRNL TITL 3 THE HELIX INVOLVED IN THE ACTIVATION OF LIPOPROTEIN LIPASE JRNL REF BIOCHEMISTRY V. 42 1872 2003 JRNL REFN ISSN 0006-2960 JRNL PMID 12590574 JRNL DOI 10.1021/BI0267184 REMARK 2 REMARK 2 RESOLUTION. NOT APPLICABLE. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : X-PLOR REMARK 3 AUTHORS : BRUNGER REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: IN ADDITION TO CLASSICAL NMR REMARK 3 CONSTRAINTS THREE TYPES OF GLOBAL CONSTRAINTS WERE USED TO REMARK 3 DEFINE THE GLOBAL STRUCTURE OF APO-CII IN THE APO-CII/SDS- REMARK 3 MICELLE COMPLEX. SCRIPTS FOR THE GLOBAL STRUCTURE DETERMINATION REMARK 3 HAVE BEEN WRITTEN AND ARE AVAILABLE UPON REQUEST. FINALLY, CNS REMARK 3 WAS USED FOR THE FINAL MINIMIZATION. REMARK 4 REMARK 4 1O8T COMPLIES WITH FORMAT V. 3.15, 01-DEC-08 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 29-NOV-02. REMARK 100 THE DEPOSITION ID IS D_1290011810. REMARK 210 REMARK 210 EXPERIMENTAL DETAILS REMARK 210 EXPERIMENT TYPE : NMR REMARK 210 TEMPERATURE (KELVIN) : 313 REMARK 210 PH : 4.5 REMARK 210 IONIC STRENGTH : 10 MM ACETIC ACID 380 MM SDS REMARK 210 PRESSURE : 1 ATM REMARK 210 SAMPLE CONTENTS : NULL REMARK 210 REMARK 210 NMR EXPERIMENTS CONDUCTED : CBCANHCBCA(CO)NHCBCACO(N) REMARK 210 HHNCOSPIN-LOCK HCANHHCC(CO) NH1H- REMARK 210 15N NOESY-HSQC2D NOESY1H-15N REMARK 210 HNHA15N T115N T215N-{1H} NOE REMARK 210 SPECTROMETER FIELD STRENGTH : 600 MHZ; 500 MHZ; 400 MHZ REMARK 210 SPECTROMETER MODEL : DRX; AMX REMARK 210 SPECTROMETER MANUFACTURER : BRUKER REMARK 210 REMARK 210 STRUCTURE DETERMINATION. REMARK 210 SOFTWARE USED : XEASY, SYBYL, X-PLOR, CNS REMARK 210 METHOD USED : RESTRAINT MOLECULAR DYNAMICS REMARK 210 REMARK 210 CONFORMERS, NUMBER CALCULATED : 100 REMARK 210 CONFORMERS, NUMBER SUBMITTED : 68 REMARK 210 CONFORMERS, SELECTION CRITERIA : LEAST ENERGY, LEAST RESTRAINT REMARK 210 VIOLATION REMARK 210 REMARK 210 BEST REPRESENTATIVE CONFORMER IN THIS ENSEMBLE : 1 REMARK 210 REMARK 210 REMARK: NULL REMARK 215 REMARK 215 NMR STUDY REMARK 215 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM SOLUTION REMARK 215 NMR DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE THAT REMARK 215 CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES ON REMARK 215 THESE RECORDS ARE MEANINGLESS. REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 400 REMARK 400 COMPOUND REMARK 400 APOC-II IS A COMPONENT OF THE VERY LOW DENSITY REMARK 400 LIPOPROTEIN (VLDL) FUNCTIONS AS AN ACTIVATOR OF REMARK 400 SEVERAL TRIACYLGLYCEROL LIPASES. REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 1 PRO A 10 76.14 -66.76 REMARK 500 1 VAL A 18 -48.52 -29.72 REMARK 500 2 GLN A 3 119.06 -163.57 REMARK 500 2 PRO A 10 94.04 -63.82 REMARK 500 2 VAL A 18 -51.34 -29.93 REMARK 500 2 PRO A 43 34.07 -85.87 REMARK 500 2 GLU A 78 36.30 -140.83 REMARK 500 3 ASP A 7 -156.52 -71.21 REMARK 500 3 PHE A 14 -49.03 -149.87 REMARK 500 3 VAL A 18 -49.34 -29.96 REMARK 500 4 PHE A 14 -79.89 -145.73 REMARK 500 4 PRO A 43 44.80 -93.16 REMARK 500 5 GLN A 3 71.97 63.88 REMARK 500 5 GLU A 8 -73.32 -70.15 REMARK 500 5 PHE A 14 -15.63 82.03 REMARK 500 5 GLU A 78 44.92 -158.59 REMARK 500 6 GLN A 2 107.32 67.57 REMARK 500 6 PHE A 14 -70.50 -116.80 REMARK 500 6 PRO A 43 35.35 -92.99 REMARK 500 7 GLN A 5 -70.60 -72.67 REMARK 500 7 GLN A 6 -178.39 -67.83 REMARK 500 7 PHE A 14 -59.51 -138.95 REMARK 500 7 PRO A 43 33.92 -92.12 REMARK 500 8 GLN A 6 73.38 -67.89 REMARK 500 8 PRO A 12 103.04 -49.35 REMARK 500 8 GLU A 78 38.50 -145.03 REMARK 500 9 PHE A 14 -73.27 -118.33 REMARK 500 9 VAL A 18 -52.66 -29.96 REMARK 500 10 PRO A 4 30.27 -84.82 REMARK 500 10 PHE A 14 -50.87 -149.39 REMARK 500 10 VAL A 18 -52.05 -29.99 REMARK 500 10 GLU A 78 -60.47 -168.15 REMARK 500 11 GLN A 2 121.02 68.12 REMARK 500 11 VAL A 18 -54.52 -29.73 REMARK 500 11 PRO A 43 33.83 -91.50 REMARK 500 12 GLN A 2 -64.41 -122.44 REMARK 500 12 PRO A 4 40.27 -88.36 REMARK 500 12 GLN A 6 -157.27 -67.84 REMARK 500 12 VAL A 18 -50.06 -29.35 REMARK 500 12 PRO A 43 48.36 -92.30 REMARK 500 13 GLN A 2 48.45 -107.92 REMARK 500 13 GLN A 3 -70.03 -131.05 REMARK 500 13 VAL A 18 -54.08 -29.54 REMARK 500 14 PHE A 14 -55.40 -155.87 REMARK 500 14 VAL A 18 -48.02 -29.58 REMARK 500 15 PRO A 4 81.08 -69.90 REMARK 500 15 VAL A 18 -45.94 -29.73 REMARK 500 15 GLU A 78 -73.16 -174.19 REMARK 500 16 PRO A 10 86.35 -69.57 REMARK 500 16 PHE A 14 -51.75 -154.24 REMARK 500 REMARK 500 THIS ENTRY HAS 215 RAMACHANDRAN OUTLIERS. REMARK 500 REMARK 500 REMARK: NULL REMARK 650 REMARK 650 HELIX REMARK 650 DETERMINATION METHOD: AUTHOR PROVIDED. REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1BY6 RELATED DB: PDB REMARK 900 PEPTIDE OF HUMAN APOLIPOPROTEIN C-II REMARK 900 RELATED ID: 1I5J RELATED DB: PDB REMARK 900 NMR STRUCTURE OF HUMAN APOLIPOPROTEIN C-II IN THE PRESENCE OF SDS DBREF 1O8T A 1 79 UNP P02655 APC2_HUMAN 23 101 SEQRES 1 A 79 THR GLN GLN PRO GLN GLN ASP GLU MET PRO SER PRO THR SEQRES 2 A 79 PHE LEU THR GLN VAL LYS GLU SER LEU SER SER TYR TRP SEQRES 3 A 79 GLU SER ALA LYS THR ALA ALA GLN ASN LEU TYR GLU LYS SEQRES 4 A 79 THR TYR LEU PRO ALA VAL ASP GLU LYS LEU ARG ASP LEU SEQRES 5 A 79 TYR SER LYS SER THR ALA ALA MET SER THR TYR THR GLY SEQRES 6 A 79 ILE PHE THR ASP GLN VAL LEU SER VAL LEU LYS GLY GLU SEQRES 7 A 79 GLU HELIX 1 1 THR A 16 GLU A 38 1 23 HELIX 2 2 VAL A 45 ALA A 58 1 14 HELIX 3 3 THR A 64 VAL A 74 1 11 CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 1 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 1.000000 0.000000 0.000000 0.00000 SCALE2 0.000000 1.000000 0.000000 0.00000 SCALE3 0.000000 0.000000 1.000000 0.00000 MODEL 1